Benzinga | Feb 25, 2021 05:19AM EST

SVB Leerink Maintains Outperform on Repligen, Raises Price Target to $250

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $220 to $250.